ATAI Life Sciences to Invest $5 Million in Bitcoin Treasury Strategy

Biopharmaceutical company atai Life Sciences (ATAI) plans to implement a bitcoin (BTC) treasury strategy. Chairman Christian Angermayer announced the initiative, raising questions about how investing in bitcoin can help biotech firms manage capital during inflation and market volatility.

• The company will invest $5 million in bitcoin.
• ATAI will maintain sufficient cash and securities for operational expenses until 2027.
• This move follows a trend among companies adopting similar strategies to that of Michael Saylor.
• ATAI shares briefly increased but are now down 2.8% today.
• Bitcoin peaked at $87,000 before declining to $83,900, a 1% decrease over 24 hours.